Optimal timing of percutaneous transhepatic gallbladder drainage and subsequent laparoscopic cholecystectomy according to the severity of acute cholecystitis
Annals of Hepato-Biliary-Pancreatic Surgery · 31.05.2022 · 26 (2) · 159-167
DOI: 10.14701/ahbps.21-125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hepato-Biliary-Pancreatic Surgery, erschienen am 31.05.2022. Verfasst von Jung Suk Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea.
ORCID-Profile: Jung Suk Lee, Seung Jae Lee, In Seok Choi, Ju Ik Moon
Zitieren
APA
Lee, J. S., Lee, S. J., Choi, I. S., & Moon, J. I. (2022). Optimal timing of percutaneous transhepatic gallbladder drainage and subsequent laparoscopic cholecystectomy according to the severity of acute cholecystitis. Annals of Hepato-Biliary-Pancreatic Surgery, 26(2), 159-167. https://doi.org/10.14701/ahbps.21-125
Vancouver
Lee JS, Lee SJ, Choi IS, Moon JI. Optimal timing of percutaneous transhepatic gallbladder drainage and subsequent laparoscopic cholecystectomy according to the severity of acute cholecystitis. Annals of Hepato-Biliary-Pancreatic Surgery. 2022;26(2):159-167. doi:10.14701/ahbps.21-125
BibTeX
@article{Lee2022,
author = {Lee, Jung Suk and Lee, Seung Jae and Choi, In Seok and Moon, Ju Ik},
title = {Optimal timing of percutaneous transhepatic gallbladder drainage and subsequent laparoscopic cholecystectomy according to the severity of acute cholecystitis},
journal = {Annals of Hepato-Biliary-Pancreatic Surgery},
year = {2022},
volume = {26},
number = {2},
pages = {159--167},
doi = {10.14701/ahbps.21-125}
}
EUVIMED